Jeantine Lunshof

Jeantine Lunshof is a philosopher and bioethicist. Since 1992, she has been involved in international research collaborations on ethical issues in human genetics. She holds affiliations with the Department of Molecular Cell Physiology, VU University, Amsterdam, The Netherlands, The Netherlands Institute for Systems Biology (NISB), and with (CESAGen), Cardiff University, UK. Her current work focuses on the ethical and public-policy aspects of pharmacogenomics, genome-wide association studies and personalized medicine, and on the philosophy of systems biology. Jeantine has been an ethics consultant to the Personal Genome Project at Harvard Medical School, Genetics Department, since early 2006. She is an affiliate member of the NIH Pharmacogenetics Research Network (PGRN), and a Member of the Public Population Project in Genomics (P3G) Consortium.

Biography Updated on 29 May 2008

Personal Home Page

http://www.bio.vu.nl/microb/personnel/jeantine_lunshof/index.html

Articles in Scholarly Journals [Incomplete List]

  1. Hippocrates revisited? Old ideals and new realities
    Genomic Medicine, 2008
  2. From genetic privacy to open consent
    Nature Reviews Genetics, vol. 9, no. 5, Article ID nrg2360, 5 pages, 2008
  3. Personalized medicine: decades away?
    Pharmacogenomics, vol. 7, no. 2, pp. 237–241, 2006
  4. Teaching and practicing pharmacogenomics: a complex matter
    Pharmacogenomics, vol. 7, no. 2, pp. 243–246, 2006
  5. Personalized medicine: new perspectives - new ethics?
    Personalized Medicine, vol. 3, no. 2, pp. 187–194, 2006
  6. Desperate times call for desperate measures
    Nature Reviews Genetics, vol. 7, no. 3, pp. 162–162, 2006
  7. Molecular medicine: a lifetime of learning, teaching and caring
    Trends in Molecular Medicine, vol. 11, no. 11, pp. 484–485, 2005
  8. A call for the creation of personalized medicine databases
    Nature Reviews Drug Discovery, vol. 5, no. 1, pp. 23–26, 2005
  9. Personalized medicine: how much can we afford? A bioethics perspective
    Personalized Medicine, vol. 2, no. 1, pp. 43–47, 2005
  10. Pharmacogenomics, drug development, and ethics: Some points to consider
    Drug Development Research, vol. 62, no. 2, pp. 112–116, 2004